SCHEMBL672105

SCHEMBL672105

O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.59
TSHR P16473 4/20 0.52
MAPK1 P28482 1/20 0.52
ALDH1A1 P00352 2/20 0.46
VCAM1 P19320 6/20 0.46
GPR35 Q9HC97 1/20 0.45
HSD17B10 Q99714 1/20 0.43
TXNRD1 Q16881 1/20 0.43
TXNRD3 Q86VQ6 1/20 0.43
TXNRD2 Q9NNW7 1/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30946523 1.00 TDP1 (0.59) TDP1TSHRMAPK1ALDH1A1VCAM1
Acetone SCHEMBL27645515 0.90 TDP1 (0.50) TDP1TSHRMAPK1ALDH1A1VCAM1
Alcohol SCHEMBL27912165 0.89 TDP1 (0.48) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL7514813 0.88 ALDH1A1 (0.56) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL29702010 0.88 ALDH1A1 (0.56) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL3302919 0.85 TSHR (0.56) TDP1TSHRMAPK1ALDH1A1GPR35
SCHEMBL2160036 0.84 TDP1 (0.69) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL2145586 0.84 TDP1 (0.69) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL29918148 0.84 TDP1 (0.69) TDP1TSHRMAPK1ALDH1A1VCAM1
Fluoride SCHEMBL10977459 0.83 TDP1 (0.67) TDP1TSHRMAPK1ALDH1A1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207381-A1 BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF BIOVAXYS INC (US) 2024-06-27 US claimed
CN-118179542-A Carbon-based catalyst, and preparation method and application thereof 中国石油化工股份有限公司 2024-06-14 CN claimed
CN-118084791-A High-energy-density compound based on polynitrobenzene bipyrazole and synthesis method thereof 南京理工大学 2024-05-28 CN claimed
CN-117986570-A Wholly aromatic polyester amide resin and preparation method thereof 中国科学院成都有机化学有限公司 2024-05-07 CN claimed
EP-4329779-A1 BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF BioVaxys Inc. (US) 2024-03-06 EP claimed
US-20230149534-A1 HAPTENIZED CORONAVIRUS SPIKE PROTEINS BIOVAXYS LLC 2023-05-18 US claimed
WO-2023060220-A1 METHODS OF IMMUNIZATION AGAINST CORONAVIRUS BioVaxys Inc. (US) 2023-04-13 WO claimed
CN-115916253-A Haptenylated coronavirus spike protein 拜奥维萨公司 2023-04-04 CN claimed
EP-4121103-A1 HAPTENIZED CORONAVIRUS SPIKE PROTEINS BioVaxys Inc. (US) 2023-01-25 EP claimed
WO-2022232221-A1 BIHAPTENIZED AUTOLOGOUS VACCINES AND USES THEREOF BIOVAXYS, INC. (US) 2022-11-03 WO claimed
EP-2368575-B1 Dry formulation for transcutaneous immunization INTERCELL USA INC (US) 2014-10-01 EP claimed
CN-103304482-A Multi-nitrobenzene substituted nitroimidazole energetic compound and preparation method thereof UNIV NANJING SCIENCE & TECH 2013-09-18 CN claimed
CN-100532377-C Compound containing tetrazine polynitrobenzene and synthesis method thereof BEIJING INST TECHNOLOGY (CN) 2009-08-26 CN claimed
EP-1016405-A2 Arylating medicaments Radopath Pharmaceuticals International Limited (GB) 2000-07-05 EP claimed
US-5635361-A OBTAINING BLOOD SAMPLE, ASSAYING IN VITRO THE BINDING OF LEUKOCYTES OF SAMPLE WITH TUMOR MIMETIC CELL SURFACE ANTIGEN PRODUCED BY CHEMICAL TREATMENT OF HUMAN NORMAL CELLS WITH HALONITROBENZENES, CROSS-REACTS WITH TUMOR ANTIGENS SAHASRABUDHE, VIKAS M. 1997-06-03 US claimed
EP-0769309-A2 Extinguishing chain for fighting fires Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 1997-04-23 EP claimed
CN-1124012-A Arylating medicaments RADOPATH LTD (GB) 1996-06-05 CN claimed
EP-0700287-A1 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1996-03-13 EP claimed
WO-1994027584-A2 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1994-12-08 WO claimed
EP-0493638-A1 Novel composite explosives and method for making them UNION ESPANOLA DE EXPLOSIVOS S.A. (ES) 1992-07-08 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149534-A1 HAPTENIZED CORONAVIRUS SPIKE PROTEINS ACE2, CD14, TMPRSS2 TDP1 4545/4885TSHR 4289/4885MAPK1 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.